Q2 2020 Biohaven Pharmaceutical Holding Company Ltd Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Biohaven Pharmaceuticals Second Quarter 2020 Results Call. (Operator Instructions) Please be advised that today's conference may be recorded.
I would now like to hand the conference over to Biohaven's Chief Operating Officer, Clifford Bechtold. Thank you, and please go ahead.
Good morning. Thank you, and welcome to the Second Quarter 2020 Earnings Call. Speaking today are -- sorry, speaking this morning on today's call is Dr. Vlad Coric, our Chief Executive Officer; Jim Engelhart, Chief Financial Officer; BJ Jones, our Chief Commercial Officer; and Elyse Stock, our Clinical Medical Officer.
Earlier this morning, we issued a press release announcing our second quarter 2020 highlights. A copy of this press release can be found on our website at biohavenpharma.com.
Before we begin today's presentation, I would like to remind you that various remarks
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |